Largest pharmaceuticals by total liabilities
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
AbbVie leads the 61 pharmaceuticals ranked by total liabilities, at CZK 3.05T, ahead of Pfizer (CZK 2.7T) and Johnson & Johnson (CZK 2.62T). Figures as of 18 Nov 2026, 14:23 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- AbbVieCZK 3.05T
- Median
- CZK 46.3B
- Combined market value
- CZK 114.67T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Total liabilities ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AbbVieABBV · Health Care | CZK 3.05T | CZK 11.51T | CZK 6,509.48 | 0.59% down | 26% up | ||
| 2 | PfizerPFE · Health Care | CZK 2.7T | CZK 3.61T | CZK 632.90 | 1.35% down | 14% up | ||
| 3 | Johnson & JohnsonJNJ · Health Care | CZK 2.62T | CZK 14.91T | CZK 6,195.58 | 1.36% down | 38% up | ||
| 4 | Eli LillyLLY · Health Care | CZK 1.91T | CZK 28.03T | CZK 31,468.10 | 1.13% down | 35% up | ||
| 5 | Merck & CoMRK · Health Care | CZK 1.87T | CZK 7.86T | CZK 3,187.16 | 0.75% down | 51% up | ||
| 6 | Bristol-Myers SquibbBMY · Health Care | CZK 1.59T | CZK 2.79T | CZK 1,363.83 | 2.51% down | 34% up | ||
| 7 | AstraZenecaAZN · Health Care | CZK 1.45T | CZK 6.28T | CZK 4,051.92 | 0.95% down | 2% up | ||
| 8 | NovartisNVS · Health Care | CZK 1.43T | CZK 6.68T | CZK 3,537.51 | 0.67% down | 25% up | ||
| 9 | SanofiSNY · Health Care | CZK 1.36T | CZK 2.54T | CZK 1,056.61 | 1.78% down | 4% down | ||
| 10 | GSKGSK · Health Care | CZK 1.33T | CZK 2.19T | CZK 1,094.62 | 2.32% down | 6% up | ||
| 11 | Novo NordiskNVO · Health Care | CZK 1.15T | CZK 3.99T | CZK 904.77 | 2.16% down | 17% down | ||
| 12 | Takeda PharmaceuticalTAK · Health Care | CZK 1.13T | CZK 1.54T | CZK 481.06 | 0.23% up | 54% up | ||
| 13 | Abbott LaboratoriesABT · Health Care | CZK 754.5B | CZK 4.03T | CZK 2,327.73 | 2.55% down | 17% down | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | CZK 729.9B | CZK 1.11T | CZK 947.46 | 0.12% up | 74% up | ||
| 15 | ViatrisVTRS · Health Care | CZK 499.8B | CZK 521.2B | CZK 454.61 | 1.40% down | 96% up | ||
| 16 | GrifolsGRFS · Health Care | CZK 298.7B | CZK 130.6B | CZK 191.85 | 1.15% down | 1% up | ||
| 17 | ZoetisZTS · Health Care | CZK 269.8B | CZK 754B | CZK 1,855.79 | 1.08% down | 29% down | ||
| 18 | Royalty PharmaRPRX · Health Care | CZK 220.2B | CZK 877.9B | CZK 1,526.78 | 0.23% up | 78% up | ||
| 19 | Regeneron PharmaceuticalsREGN · Health Care | CZK 206.8B | CZK 2.2T | CZK 21,291.29 | 0.56% up | 36% up | ||
| 20 | Jazz PharmaceuticalsJAZZ · Health Care | CZK 163.2B | CZK 343.5B | CZK 5,351.06 | 0.39% up | 37% up | ||
| 21 | GenmabGMAB · Health Care | CZK 156.2B | CZK 712.2B | CZK 1,155.09 | 0.76% up | 70% up | ||
| 22 | Vertex PharmaceuticalsVRTX · Health Care | CZK 155.1B | CZK 3.01T | CZK 11,875.43 | 0.67% down | 27% up | ||
| 23 | Elanco Animal HealthELAN · Health Care | CZK 151.4B | CZK 287.2B | CZK 574.65 | 2.12% down | 20% up | ||
| 24 | Alnylam PharmaceuticalsALNY · Health Care | CZK 92.9B | CZK 466B | CZK 3,479.04 | 2.02% down | 66% down | ||
| 25 | BeOne MedicinesONC · Health Care | CZK 85.1B | CZK 1.05T | CZK 9,186.89 | 0.48% up | 17% up | ||
| 26 | Amneal PharmaceuticalsAMRX · Health Care | CZK 81.6B | CZK 163.6B | CZK 469.50 | 0.52% down | 83% up | ||
| 27 | PTC TherapeuticsPTCT · Health Care | CZK 69B | CZK 112.1B | CZK 1,341.82 | 1.00% down | 20% down | ||
| 28 | Ionis PharmaceuticalsIONS · Health Care | CZK 67.5B | CZK 99.8B | CZK 599.33 | 3.75% down | 64% down | ||
| 29 | BridgeBio PharmaBBIO · Health Care | CZK 67B | CZK 332.6B | CZK 1,707.29 | 0.72% down | 17% up | ||
| 30 | Dr. Reddy's LaboratoriesRDY · Health Care | CZK 47B | CZK 274.1B | CZK 328.79 | 0.61% up | 5% up | ||
| 31 | CytokineticsCYTK · Health Care | CZK 46.3B | CZK 159.9B | CZK 1,148.19 | 2.86% down | 20% down | ||
| 32 | Ascendis PharmaASND · Health Care | CZK 36.1B | CZK 395.4B | CZK 6,028.64 | 0.20% down | 28% up | ||
| 33 | InsmedINSM · Health Care | CZK 33.9B | CZK 594.3B | CZK 2,708.98 | 0.83% down | 40% down | ||
| 34 | BioMarin PharmaceuticalBMRN · Health Care | CZK 33.5B | CZK 251.9B | CZK 1,300.69 | 0.90% up | 11% up | ||
| 35 | Arrowhead PharmaceuticalsARWR · Health Care | CZK 19.6B | CZK 135.1B | CZK 955.68 | 2.76% down | 10% up | ||
| 36 | United TherapeuticsUTHR · Health Care | CZK 17.4B | CZK 553B | CZK 12,984.72 | 0.64% down | 23% up | ||
| 37 | Legend BiotechLEGN · Health Care | CZK 16.3B | CZK 69.5B | CZK 358.13 | 0.75% up | 42% down | ||
| 38 | AlkermesALKS · Health Care | CZK 14.8B | CZK 169.8B | CZK 1,010.37 | 2.32% down | 58% up | ||
| 39 | Madrigal PharmaceuticalsMDGL · Health Care | CZK 14.6B | CZK 217.9B | CZK 9,380.96 | 0.46% down | 24% down | ||
| 40 | Axsome TherapeuticsAXSM · Health Care | CZK 13.4B | CZK 159B | CZK 3,022.21 | 0.77% down | 7% down | ||
| 41 | Ligand PharmaceuticalsLGND · Health Care | CZK 12.1B | CZK 130.6B | CZK 6,531.48 | 2.62% down | 43% up | ||
| 42 | Mirum PharmaceuticalsMIRM · Health Care | CZK 11.7B | CZK 133.4B | CZK 2,044.08 | 0.40% up | 31% up | ||
| 43 | Travere TherapeuticsTVTX · Health Care | CZK 10.9B | CZK 109B | CZK 1,135.97 | 2.82% up | 44% up | ||
| 44 | Roivant SciencesROIV · Health Care | CZK 9.3B | CZK 623.5B | CZK 860.53 | 0.26% up | 90% up | ||
| 45 | TG TherapeuticsTGTX · Health Care | CZK 9.2B | CZK 210.7B | CZK 1,394.06 | 0.08% down | 107% up | ||
| 46 | Cogent BiosciencesCOGT · Health Care | CZK 6.7B | CZK 107.7B | CZK 619.11 | 1.49% up | 20% down | ||
| 47 | Rhythm PharmaceuticalsRYTM · Health Care | CZK 4.7B | CZK 179.7B | CZK 2,592.28 | 8.49% up | 13% up | ||
| 48 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | CZK 4.4B | CZK 166.1B | CZK 2,114.32 | 0.93% up | 126% up | ||
| 49 | Corcept TherapeuticsCORT · Health Care | CZK 4.2B | CZK 170.5B | CZK 1,557.68 | 1.23% up | 8% down | ||
| 50 | ABIVAXABVX · Health Care | CZK 3.2B | CZK 159.8B | CZK 1,825.11 | 1.81% down | 27% down | ||
| 51 | Definium TherapeuticsDFTX · Health Care | CZK 2.4B | CZK 89.4B | CZK 653.13 | 2.59% down | 169% up | ||
| 52 | Summit TherapeuticsSMMT · Health Care | CZK 2.1B | CZK 189.7B | CZK 237.20 | 9.73% down | 36% down | ||
| 53 | ErascaERAS · Health Care | CZK 1.6B | CZK 108.4B | CZK 308.78 | 8.07% down | 403% up | ||
| 54 | Spyre TherapeuticsSYRE · Health Care | CZK 1.4B | CZK 198.1B | CZK 2,085.42 | 5.60% down | 286% up | ||
| 55 | Praxis Precision MedicinesPRAX · Health Care | CZK 1.3B | CZK 189.6B | CZK 6,781.58 | 1.68% down | 61% up | ||
| 56 | Protagonist TherapeuticsPTGX · Health Care | CZK 1.2B | CZK 180.9B | CZK 2,771.45 | 0.13% down | 46% up | ||
| 57 | Dianthus TherapeuticsDNTH · Health Care | CZK 834.1M | CZK 108.9B | CZK 1,933.59 | 2.87% down | 113% up | ||
| 58 | Edgewise TherapeuticsEWTX · Health Care | CZK 674.6M | CZK 102.3B | CZK 934.56 | 3.75% down | 88% up | ||
| 59 | Oruka TherapeuticsORKA · Health Care | CZK 371M | CZK 145.2B | CZK 2,141.22 | 2.94% down | 241% up | ||
| 60 | Belite BioBLTE · Health Care | CZK 223.9M | CZK 142.4B | CZK 3,506.16 | 2.98% down | 31% up | ||
| 61 | VeradermicsMANE · Health Care | CZK 203.5M | CZK 117.9B | CZK 2,793.01 | 1.88% down | 233% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total liabilities is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Where a company reports no total-liabilities line, it is worked out as assets less equity. Sums are converted from US dollars at today's exchange rate (1 USD = 22.2303 CZK).
Questions and answers
Which pharmaceuticals rank first by total liabilities?
AbbVie (CZK 3.05T), Pfizer (CZK 2.7T) and Johnson & Johnson (CZK 2.62T) are the top three of the 61 pharmaceuticals ranked by total liabilities as of 18 Nov 2026, 14:23 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by total liabilities.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by total liabilities have a combined market value of CZK 114.67T as of 18 Nov 2026, 14:23 UTC.
What does ranking by total liabilities measure?
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceuticals by total liabilities”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=total-liabilities
Underlying data: Yahoo Finance; SEC EDGAR.